Company Filing History:
1 out of 870 
1 out of 454 
1 out of 5,101 
Years Active: 2007
Title: The Innovative Mind of Aarne Fleischer
Introduction
Aarne Fleischer is a notable inventor based in Paris, France, recognized for his contributions to the field of apoptosis research. His innovative methods in screening compounds have the potential to enhance therapeutic applications significantly. With a focus on understanding the intricacies of cellular behavior, Fleischer’s work paves the way for advancements in medical treatments.
Latest Patents
Fleischer holds a patent titled "Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents." This patent outlines a method for screening cellular polypeptides for pro-apoptotic or anti-apoptotic activity. The process involves culturing specific cell types under non-apoptotic and apoptotic conditions, alongside determining the subcellular localization of the polypeptides. Notably, the localization of cellular polypeptides in lipid rafts under non-apoptotic conditions, and their segregation from these rafts under apoptotic conditions, indicates their potential role as either pro-apoptotic or anti-apoptotic agents.
Career Highlights
Throughout his career, Aarne Fleischer has worked with prestigious institutions, including the Institut Pasteur and the Consejo Superior de Investigaciones Científicas. His time at these esteemed organizations allowed him to collaborate with other experts and contribute to significant advancements in his field.
Collaborations
Fleischer has collaborated with talented individuals such as Alphonse Garcia and Xavier Cayla. These partnerships have played a vital role in the development of his innovative research and the practical application of his findings in therapeutic contexts.
Conclusion
Aarne Fleischer exemplifies the spirit of innovation through his unique approaches to understanding apoptosis and developing methods that may lead to groundbreaking therapeutic applications. His contributions not only highlight the importance of collaboration in research but also represent the potential impact of innovation in healthcare.